TGA to Use Virtual GMP Inspections While Pandemic Lasts

Australia’s Therapeutic Goods Administration (TGA) is opting to conduct its domestic good manufacturing practice inspections remotely instead of on-site during the COVID-19 pandemic.

The agency said routine on-site inspections will begin again once pandemic restrictions are lifted.

The move is expected to minimize disruptions by reducing the need for on-site inspections where social distancing might be difficult to achieve, the TGA said.